Roman Gulati

8.5k total citations
128 papers, 3.6k citations indexed

About

Roman Gulati is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Roman Gulati has authored 128 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 66 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Roman Gulati's work include Prostate Cancer Treatment and Research (83 papers), Prostate Cancer Diagnosis and Treatment (56 papers) and Global Cancer Incidence and Screening (33 papers). Roman Gulati is often cited by papers focused on Prostate Cancer Treatment and Research (83 papers), Prostate Cancer Diagnosis and Treatment (56 papers) and Global Cancer Incidence and Screening (33 papers). Roman Gulati collaborates with scholars based in United States, South Africa and Netherlands. Roman Gulati's co-authors include Ruth Etzioni, Alex Tsodikov, John L. Gore, Angela B. Mariotto, Peter S. Nelson, David F. Penson, Eric J. Feuer, Bruce Montgomery, Colm Morrissey and Seth Falcon and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Roman Gulati

120 papers receiving 3.6k citations

Peers

Roman Gulati

PRM

ONCOL

SURGE

Mauricio Burotto United States

Adolfo Favaretto Italy

Antoine Thiery-Vuillemin France

Masashi Ando Japan

Shenghui Tang United States

Bruce J. Giantonio United States

Robert B. Den United States

Julia A. Beaver United States

Kanwal Raghav United States

Jyoti D. Patel United States

Mauricio Burotto United States

Roman Gulati

1.5k ×0.7

PRM

1.9k ×1.2

ONCOL

1.3k ×2.0

746 ×1.1

394 ×1.0

SURGE

Citations per year, relative to Roman Gulati Roman Gulati (= 1×) peers Mauricio Burotto

Countries citing papers authored by Roman Gulati

Since Specialization

Citations

This map shows the geographic impact of Roman Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Gulati more than expected).

Fields of papers citing papers by Roman Gulati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Gulati. The network helps show where Roman Gulati may publish in the future.

Co-authorship network of co-authors of Roman Gulati

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Gulati. A scholar is included among the top collaborators of Roman Gulati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Gulati. Roman Gulati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gulati, Roman, Jane Lange, Antonio Olivas‐Martínez, et al.. (2025). Sensitivity Measures in Studies of Cancer Early Detection Biomarkers. Cancer Epidemiology Biomarkers & Prevention. 34(6). 944–951.

Fung, Adrian Chi Heng, et al.. (2025). Trends in young-onset cancer incidence: a modeling perspective. JNCI Journal of the National Cancer Institute. 117(7). 1350–1359. 4 indexed citations

Caverly, Tanner, Matthew J. Schipper, Timothy P. Hofer, et al.. (2025). Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening. JAMA Network Open. 8(2). e2459766–e2459766. 1 indexed citations

Cheng, Heather H., Roman Gulati, Michael T. Schweizer, et al.. (2025). Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency. European Urology Oncology. 9(1). 37–44. 1 indexed citations

Lange, Jane, et al.. (2024). Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling. Cancer Epidemiology Biomarkers & Prevention. 33(6). 830–837. 8 indexed citations

Mo, George, Laura Graham, Roman Gulati, et al.. (2024). Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to ¹⁷⁷Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO Precision Oncology. 8(8). e2300634–e2300634. 7 indexed citations

Gulati, Roman, Heather H. Cheng, Jessica E. Hawley, et al.. (2024). Hematologic toxicity in ¹⁷⁷lu-PSMA-617 treatment for mCRPC: Unraveling the impact of PSMA PET bone tumor volume (PSMA-bTTV).. Journal of Clinical Oncology. 42(16_suppl). 5075–5075. 3 indexed citations

Gulati, Roman, Jessica E. Hawley, Todd Yezefski, et al.. (2024). SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving¹⁷⁷Lu-PSMA-617. Journal of Nuclear Medicine. 65(12). jnumed.124.267665–jnumed.124.267665. 4 indexed citations

Menon, Usha, et al.. (2023). Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?. Cancer Epidemiology Biomarkers & Prevention. 32(6). 741–743. 3 indexed citations

10.

Etzioni, Ruth, Roman Gulati, Christos Patriotis, et al.. (2023). Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies. JNCI Journal of the National Cancer Institute. 116(2). 189–193. 14 indexed citations

11.

Jiao, Boshen, Roman Gulati, Hormuzd A. Katki, Philip E. Castle, & Ruth Etzioni. (2021). A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing. Cancer Epidemiology Biomarkers & Prevention. 31(1). 38–44. 13 indexed citations

12.

Corella, Alexandra, Ilsa M. Coleman, Jared M. Lucas, et al.. (2019). Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer. Clinical Cancer Research. 26(7). 1667–1677. 32 indexed citations

13.

Schenk, Jeannette M., Marian L. Neuhouser, Daniel W. Lin, et al.. (2019). Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS). Contemporary Clinical Trials. 81. 34–39. 13 indexed citations

14.

Ryser, Marc D., Roman Gulati, Marisa C. Eisenberg, et al.. (2018). Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials. American Journal of Epidemiology. 188(1). 197–205. 12 indexed citations

15.

Ryser, Marc D., Donald L. Weaver, Fengmin Zhao, et al.. (2018). Cancer Outcomes in DCIS Patients Without Locoregional Treatment. JNCI Journal of the National Cancer Institute. 111(9). 952–960. 85 indexed citations

16.

Mostaghel, Elahe A., Eunpi Cho, Ailin Zhang, et al.. (2017). Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer. Clinical Cancer Research. 23(16). 4592–4601. 31 indexed citations

17.

Lam, Hung‐Ming, Ryan P. McMullin, Holly M. Nguyen, et al.. (2016). Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts. Clinical Cancer Research. 23(9). 2301–2312. 17 indexed citations

18.

Feng, Ziding, Roman Gulati, Jing Fan, et al.. (2015). Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 24(4). 677–682. 15 indexed citations

19.

Xia, Jing, Bruce J. Trock, Roman Gulati, et al.. (2014). Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics. Clinical Cancer Research. 20(20). 5302–5310. 13 indexed citations

20.

Gulati, Roman, Elisabeth M. Wever, Alex Tsodikov, et al.. (2011). What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models. Cancer Epidemiology Biomarkers & Prevention. 20(5). 740–750. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact